Beryl Capital Management Portfolio holdings

Beryl Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Beryl Capital Management held 47 positions worth $182M, down 80% from $896M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Beryl Capital Management withdrew a net $617M in Q4 2023, closing 27 positions and reducing 3 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $236M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Beryl Capital Management opened a new position in Splunk Inc worth $34M.

• Beryl Capital Management's largest Q4 2023 buy was Splunk Inc: 222,921 shares worth $34M.
• Beryl Capital Management added most to Diversified Healthcare Trust in Q4 2023, an estimated $588K increase.
• Beryl Capital Management's biggest Q4 2023 reduction was Silicon Motion, cutting an estimated $12M.
• Beryl Capital Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $236M.
• Beryl Capital Management's ten largest holdings make up 91% of its $182M portfolio in Q4 2023.
• Beryl Capital Management opened 16 new positions and closed 27 in Q4 2023.
• Beryl Capital Management's portfolio value fell 80% quarter-over-quarter to $182M.

Based on Beryl Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.